Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines episode artwork

EPISODE · Jan 22, 2026 · 1H 5M

Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines

from The Long Run with Luke Timmerman · host Timmerman Report

Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.

Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.

NOW PLAYING

Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines

0:00 1:05:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 5 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on January 22, 2026.

What is this episode about?

Ron Renaud, CEO of Waltham, Mass.-based Kailera Therapeutics, on developing GLP-1 based medicines to help people lose weight and live healthier lives.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!